Biologik ApS: Financial statements 2019
CVR: 36070498
Source: annual report 2019, Danish Business Authority
01/07/2018 – 30/06/2019
Biologik ApS (CVR 36070498) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 831,546 and a net result of DKK 183,339 compared with DKK 173,671 the year before. That is an increase of 16.4% compared with the year before. Equity in the 2019 report amounted to DKK 237,155. The solvency ratio was 40.5%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 831,546
- Profit/Loss
- DKK 183,339
- Equity
- DKK 237,155
- Total Assets
- DKK 585,746
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 832 t. | 183 t. | 237 t. | 1 |
| 2018 | - | 714 t. | 174 t. | 107 t. | 1 |
| 2017 | - | 142 t. | 47 t. | -67 t. | 1 |
| 2016 | - | 127 t. | -94 t. | -114 t. | - |
| 2015 | - | 110 t. | -70 t. | -20 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout Biologik ApS
Biologik ApS is a Danish company of the type Anpartsselskab based in Kgs. Lyngby, founded in 2014. The company is registered under the industry Drift af sundhedsvæsen i øvrigt i.a.n.. The management consists of Anette Sams Nielsen. The company is owned by Helms & Sams ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 385,601 and a net result of DKK 234,499 compared with DKK -35,348 the year before. Equity in the 2025 report amounted to DKK 408,578.